JPRN-jRCT1080225369已完成1 期
mbilical cord-derived mesenchymal stromal cells therapy for SARS-CoV-2 infection (COVID-19) related Acute Respiratory Distress Syndrome
Human Life CORD Japan Inc.0 个研究点目标入组 12 人开始时间: 2020年8月27日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •SARS-CoV-2 positive with RT-PCR test or antigen test.
- •ARDS as defined by the Berlin definition.
- •Receiving standard of care for COVID-19 and ARDS.
排除标准
- •Receiving immunosuppressant drug except steroids.
- •Increased dose of steroids.
- •Malignant tumor, Acute myocardial infarction, Pulmonary hypertension, Dialysis.
- •Not SARS-CoV-2 infection.
研究者
相似试验
招募中
不适用
Investigator initiated trial to evaluate the safety and efficacy of umbilical cord blood-derived mesenchymal stem cells for treatment of pediatric patients with steroid-refractory acute or chronic graft versus host disease.Diseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0000389Samsung Medical Center30
已完成
1 期
Amniotic membrane-derived mesenchymal stromal cells for the treatment of steroid-resistant acute GVHDJPRN-UMIN000015017Hematology Division, Internal Medicine, Hyogo college of Medicine5
进行中（未招募）
不适用
Mesenchymal Stromal Cells (MSC) for the treatment of severe (grade II-IV) steroid-resistant Graft Versus Host Disease (GVHD): a phase I trial - MSC-GvHDGraft versus Host disease GvHD steroid resistantEUCTR2008-007869-23-ITAZIENDA OSPEDALIERA SAN GERARDO DI MONZA
尚未招募
1 期
The mesenchymal stem cell-derived extracellular vesicles for postmenopausal osteoporosisIRCT20131009014957N15Tabriz University of Medical Sciences30
已完成
不适用
Elucidation of the surrounding stromal cells malignant transformation mechanism parallel to oral cancer developmentOral cancerJPRN-UMIN000014480Department of Dentistry and Oral Surgery, Keio University School of Medicine100